基本信息
views: 182
Career Trajectory
Bio
He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society – USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group.
Research Interests
Papers共 624 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL INFECTIOUS DISEASESno. 5 (2024): 1101-1102
Clinical infectious diseases : an official publication of the Infectious Diseases Society of Americano. 1 (2024): 3-3
Infectious Disease Clinics of North America (2024)
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
CLINICAL INFECTIOUS DISEASESno. 10 (2023): 1860-1863
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESno. 2 (2023): 174-184
Load More
Author Statistics
#Papers: 625
#Citation: 23522
H-Index: 70
G-Index: 145
Sociability: 8
Diversity: 3
Activity: 117
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn